Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Centauri Therapeutics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11054
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centauri Therapeutics Ltd (Centauri Therapeutics) is a biotechnology company that discovers and develops novel molecules for life threatening diseases. The company uses alphamer technology to develop anti-infective therapeutics. Its alphamer technology is based on programmable immunity in which chemically synthesised molecules alter the naturally occurring antibodies to selected pathogens to fight against the infection. Centauri Therapeutics also develops alphamers against anti-microbial resistant (AMR) pathogens. It obtains investments from private investors and regional investment funds. The company maintains a network of collaborators in the areas of aptamer selection, drug discovery, chemistry and immunology. It operates through its research and development facility located in Sandwich, Kent. Centauri Therapeutics is headquartered in London, the UK.

Centauri Therapeutics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Centauri Therapeutics Acquires Alphamer Technology from Altermune Technologies 10
Venture Financing 11
Centauri Therapeutics Raises USD1.5 Million in Second Tranche of Financing 11
Centauri Therapeutics Raises USD4.3 Million in First Tranche of Financing 12
Partnerships 13
Peakdale Molecular Extends Research Agreement with Centauri Therapeutics 13
Horizon Discovery Forms Joint Venture with Centauri Therapeutics 14
Centauri Therapeutics Ltd – Key Competitors 15
Centauri Therapeutics Ltd – Key Employees 16
Centauri Therapeutics Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 17
Recent Developments 18
Corporate Communications 18
Feb 01, 2017: Centauri Board welcomes Jonathan Synett 18
Government and Public Interest 19
Sep 11, 2017: Centauri Therapeutics receives Innovate UK Biomedical Catalyst Award 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centauri Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Centauri Therapeutics Acquires Alphamer Technology from Altermune Technologies 10
Centauri Therapeutics Raises USD1.5 Million in Second Tranche of Financing 11
Centauri Therapeutics Raises USD4.3 Million in First Tranche of Financing 12
Peakdale Molecular Extends Research Agreement with Centauri Therapeutics 13
Horizon Discovery Forms Joint Venture with Centauri Therapeutics 14
Centauri Therapeutics Ltd, Key Competitors 15
Centauri Therapeutics Ltd, Key Employees 16
Centauri Therapeutics Ltd, Joint Venture 17

List of Figures
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Centauri Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Centauri Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emperor Energy Ltd (EMP):石油・ガス:M&Aディール及び事業提携情報
    Summary Emperor Energy Ltd (Emperor Energy), formerly Oil Basins Ltd, is an oil and gas company that explores, produces, and develops crude oil and natural gas properties. The company explores oil and gas properties in onshore Canning Basin of Western Australia, offshore Gippsland Basin waters of so …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Genus Power Infrastructures Ltd (GENUSPOWER):企業の財務・戦略的SWOT分析
    Summary Genus Power Infrastructures Ltd (Genus Power), a subsidiary of Kailash Group, is an electronic equipment manufacturer that develops and distributes electric energy equipment. The company’s products include metering solution products, engineering construction and contracts, solar energy solut …
  • Al Arrab Contracting Company:企業の戦略的SWOT分析
    Al Arrab Contracting Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Hong Leong Bank Bhd:企業の戦略・SWOT・財務分析
    Hong Leong Bank Bhd - Strategy, SWOT and Corporate Finance Report Summary Hong Leong Bank Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務情報
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • First American Financial Corporation:企業のM&A・事業提携・投資動向
    First American Financial Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's First American Financial Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports …
  • John Menzies Plc
    John Menzies Plc - Strategy, SWOT and Corporate Finance Report Summary John Menzies Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hibu Group Limited:戦略・SWOT・企業財務分析
    Hibu Group Limited - Strategy, SWOT and Corporate Finance Report Summary Hibu Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • SynergEyes Inc-医療機器分野:企業M&A・提携分析
    Summary SynergEyes Inc (SynergEyes) is a medical device company that offers contact lenses. The company offers hybrid contact lenses to transform vision for patients with astigmatism, presbyopia, presbyopia, myopia, hyperopia, keratoconus, and other eye conditions. It provides ultrahealth hybrid len …
  • Cofidis Participations S.A.
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Landstar System Inc (LSTR):企業の財務・戦略的SWOT分析
    Landstar System Inc (LSTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Thoresen Thai Agencies Public Company Limited:企業の戦略・SWOT・財務情報
    Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Thoresen Thai Agencies Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, opera …
  • Intrexon Corp (XON)-製薬・医療分野:企業M&A・提携分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a provider of therapeutic solutions. The company operates through its divisions such as human therapeutics, protein production, industrial products, agricultural biotech, and animal sciences. Its human therapeutics division develops therap …
  • Advaxis Inc (ADXS):製薬・医療:M&Aディール及び事業提携情報
    Summary Advaxis Inc (Advaxis) is a biotechnology company that focuses on the discovery, development and commercialization of multiple cancer immunotherapies. The company develops immunotherapies based on its proprietary Lm Technology that uses bioengineered live attenuated Listeria monocytogenes (Lm …
  • Deep Well Oil & Gas Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Deep Well Oil & Gas Inc (Deep Well Oil & Gas) is an oil and gas exploration and development company that acquires, explores and develops oil sands. The company operates HCSS Thermal Recovery Project and SAGD Thermal Recovery Project. Its SAGD Thermal Recovery Project operates Sawn Lake oil s …
  • Takeuchi Mfg. Co Ltd:企業の戦略・SWOT・財務分析
    Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Takeuchi Mfg. Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AMC Entertainment Holdings, Inc.:企業の戦略・SWOT・財務分析
    AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary AMC Entertainment Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Plenus Company Limited
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • BoneSupport AB:企業の戦略的SWOT分析
    BoneSupport AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆